Mainz Historical Income Statement

MYNZ Stock

USD 0.26 0.03 11.30%

Historical analysis of Mainz Biomed income statement accounts such as Selling General Administrative of 8.9 M can show how well Mainz Biomed BV performed in making a profits. Evaluating Mainz Biomed income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Mainz Biomed's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Mainz Biomed BV latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Mainz Biomed BV is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mainz Biomed BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Mainz Income Statement Analysis

Mainz Biomed BV Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Mainz Biomed shareholders. The income statement also shows Mainz investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Mainz Biomed Income Statement Chart

At this time, Mainz Biomed's Depreciation And Amortization is fairly stable compared to the past year. Gross Profit is likely to rise to about 535.1 K in 2024, despite the fact that Net Interest Income is likely to grow to (769.1 K).

Selling General Administrative Selling And Marketing Expenses Other Operating Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Mainz Biomed BV. It is also known as Mainz Biomed overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Mainz Biomed's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Mainz Biomed BV current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mainz Biomed BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Interest Expense	339.2K	289.3K	809.6K	419.9K
Depreciation And Amortization	209.9K	459.4K	1.0M	1.1M

Interest Expense Depreciation And Amortization

Mainz Biomed income statement Correlations

	Net Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Reconciled Depreciation	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense
Net Interest Income		-0.96	-0.9	-0.66	-0.64	-0.89	-0.97	-0.74	0.84	0.83	0.83	-0.97	0.82	-0.81	-0.74	-0.96	0.83	-0.21	0.83	-0.98
Depreciation And Amortization	-0.96		0.83	0.66	0.69	0.78	0.91	0.75	-0.86	-0.85	-0.85	0.99	-0.84	0.66	0.75	0.99	-0.85	0.41	-0.84	0.95
Interest Expense	-0.9	0.83		0.68	0.68	0.94	0.86	0.79	-0.77	-0.77	-0.77	0.84	-0.76	0.69	0.79	0.84	-0.77	0.12	-0.77	0.84
Selling General Administrative	-0.66	0.66	0.68		0.97	0.81	0.77	0.98	-0.95	-0.96	-0.96	0.71	-0.96	0.56	0.98	0.73	-0.96	-0.04	-0.96	0.5
Selling And Marketing Expenses	-0.64	0.69	0.68	0.97		0.76	0.73	0.98	-0.94	-0.94	-0.94	0.74	-0.94	0.42	0.98	0.75	-0.94	0.19	-0.94	0.5
Total Revenue	-0.89	0.78	0.94	0.81	0.76		0.94	0.86	-0.85	-0.86	-0.86	0.83	-0.86	0.82	0.86	0.83	-0.86	-0.06	-0.86	0.78
Gross Profit	-0.97	0.91	0.86	0.77	0.73	0.94		0.81	-0.9	-0.9	-0.9	0.94	-0.89	0.87	0.81	0.94	-0.9	0.09	-0.9	0.9
Other Operating Expenses	-0.74	0.75	0.79	0.98	0.98	0.86	0.81		-0.96	-0.96	-0.96	0.79	-0.97	0.55	1.0	0.81	-0.96	0.1	-0.96	0.6
Operating Income	0.84	-0.86	-0.77	-0.95	-0.94	-0.85	-0.9	-0.96		1.0	1.0	-0.9	1.0	-0.65	-0.96	-0.91	1.0	-0.17	1.0	-0.73
Net Income From Continuing Ops	0.83	-0.85	-0.77	-0.96	-0.94	-0.86	-0.9	-0.96	1.0		1.0	-0.88	1.0	-0.67	-0.96	-0.89	1.0	-0.11	1.0	-0.71
Ebit	0.83	-0.85	-0.77	-0.96	-0.94	-0.86	-0.9	-0.96	1.0	1.0		-0.88	1.0	-0.67	-0.96	-0.89	1.0	-0.11	1.0	-0.71
Research Development	-0.97	0.99	0.84	0.71	0.74	0.83	0.94	0.79	-0.9	-0.88	-0.88		-0.87	0.7	0.79	1.0	-0.88	0.37	-0.88	0.94
Ebitda	0.82	-0.84	-0.76	-0.96	-0.94	-0.86	-0.89	-0.97	1.0	1.0	1.0	-0.87		-0.67	-0.97	-0.88	1.0	-0.1	1.0	-0.7
Cost Of Revenue	-0.81	0.66	0.69	0.56	0.42	0.82	0.87	0.55	-0.65	-0.67	-0.67	0.7	-0.67		0.54	0.69	-0.67	-0.33	-0.67	0.76
Total Operating Expenses	-0.74	0.75	0.79	0.98	0.98	0.86	0.81	1.0	-0.96	-0.96	-0.96	0.79	-0.97	0.54		0.8	-0.96	0.1	-0.96	0.6
Reconciled Depreciation	-0.96	0.99	0.84	0.73	0.75	0.83	0.94	0.81	-0.91	-0.89	-0.89	1.0	-0.88	0.69	0.8		-0.89	0.37	-0.89	0.94
Income Before Tax	0.83	-0.85	-0.77	-0.96	-0.94	-0.86	-0.9	-0.96	1.0	1.0	1.0	-0.88	1.0	-0.67	-0.96	-0.89		-0.11	1.0	-0.71
Total Other Income Expense Net	-0.21	0.41	0.12	-0.04	0.19	-0.06	0.09	0.1	-0.17	-0.11	-0.11	0.37	-0.1	-0.33	0.1	0.37	-0.11		-0.1	0.29
Net Income	0.83	-0.84	-0.77	-0.96	-0.94	-0.86	-0.9	-0.96	1.0	1.0	1.0	-0.88	1.0	-0.67	-0.96	-0.89	1.0	-0.1		-0.71
Income Tax Expense	-0.98	0.95	0.84	0.5	0.5	0.78	0.9	0.6	-0.73	-0.71	-0.71	0.94	-0.7	0.76	0.6	0.94	-0.71	0.29	-0.71

Click cells to compare fundamentals

Mainz Biomed Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mainz Historical Income Statement

About Mainz Income Statement Analysis

Mainz Biomed Income Statement Chart

Other Operating Expenses

Mainz Biomed income statement Correlations

Mainz Biomed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Mainz Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Tax Provision	Net Interest Income
Depreciation And Amortization	Interest Expense
Selling General Administrative	Selling And Marketing Expenses
Total Revenue	Gross Profit
Other Operating Expenses	Operating Income
Net Income From Continuing Ops	Ebit
Research Development	Ebitda
Cost Of Revenue	Total Operating Expenses
Reconciled Depreciation	Income Before Tax
Total Other Income Expense Net	Net Income Applicable To Common Shares
Net Income	Income Tax Expense

Total Operating Expenses	+ 1.0	Other Operating Expenses
Net Income From Continuing Ops	+ 1.0	Operating Income
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Income Before Tax	+ 1.0	Operating Income
Net Income	+ 1.0	Operating Income

Income Tax Expense	- 0.98	Net Interest Income
Total Operating Expenses	- 0.97	Ebitda
Ebitda	- 0.97	Other Operating Expenses
Research Development	- 0.97	Net Interest Income
Gross Profit	- 0.97	Net Interest Income
Net Income	- 0.96	Total Operating Expenses